Лучшие больницы для «Gastric Sleeve Surgery» в Бангалор, Индия

Obesity is classified by the World Health Organization as a chronic, multifactorial disease defined by a Body Mass Index (BMI) ≥ 30 kg/m², with severe or morbid obesity designated at BMI ≥ 40 kg/m² (or ≥ 35 kg/m² with significant comorbidities). At this severity, adipose tissue dysfunction drives systemic insulin resistance, chronic low-grade inflammation, dyslipidemia, non-alcoholic fatty liver disease (NAFLD), cardiopulmonary stress, and musculoskeletal degeneration. Lifestyle interventions and pharmacotherapy alone yield less than 10% sustained weight reduction in this population, making bariatric surgery the only evidence-based intervention proven to produce durable, clinically meaningful weight loss and metabolic normalization.

Eligible CANDIDATES:

• BMI ≥ 40 kg/m² without comorbidities
• BMI ≥ 35 kg/m² with at least one significant obesity-related comorbidity: Type 2 diabetes mellitus, hypertension, obstructive sleep apnea (OSA), obesity hypoventilation syndrome, non-alcoholic steatohepatitis (NASH), gastroesophageal reflux disease (GERD — relative), hyperlipidemia, or degenerative joint disease
• BMI 30–34.9 kg/m² with inadequately controlled Type 2 diabetes or metabolic syndrome (considered on a case-by-case basis per recent IFSO/ADA guidelines)
• Age 18–65 years (exceptions considered for adolescents with severe comorbidities or patients >65 after thorough cardiopulmonary risk assessment)
• Documented failure of supervised non-surgical weight loss attempts for a minimum of 6–12 months
• +2 more

Required Pre-operative DIAGNOSTICS:

STANDARD LAPAROSCOPIC SLEEVE GASTRECTOMY (LSG) — THE GOLD STANDARD: This remains the most commonly performed bariatric procedure globally, accounting for over 45% of all weight loss surgeries performed worldwide. The procedure is performed under general anesthesia. Using a 4–5 port laparoscopic approach, the surgeon mobilizes the greater curvature of the stomach from the pylorus (approximately 2–6 cm proximal) to the angle of His using an ultrasonic energy device (e.g., Harmonic Scalpel or LigaSure). A 36–40 French orogastric bougie is inserted transorally to calibrate the sleeve diameter. A series of sequential firings of a linear stapler (typically 60 mm cartridges, progressing from green/blue loads proximally) transect the stomach, creating a narrow tubular sleeve. The resected stomach specimen is extracted via one of the port sites. Staple-line reinforcement — either with absorbable bioabsorbable polymer buttress material or continuous seromuscular oversewing — is applied at the surgeon's discretion and per institutional protocol. Operative time averages 45–90 minutes. An intraoperative leak test using methylene blue dye or air insufflation under saline is standard.

ROBOTIC-ASSISTED SLEEVE GASTRECTOMY (da Vinci Xi / Medtronic Hugo RAS): Robotic platforms offer the operating surgeon scaled motion control, tremor elimination, and a magnified 3D-HD operative field. For sleeve gastrectomy specifically, the robotic approach facilitates more precise suture-line reinforcement, improved ergonomics during the angle-of-His dissection, and better visualization in super-obese patients (BMI > 55). Evidence suggests comparable or marginally superior staple-line integrity and equivalent weight loss outcomes to standard laparoscopy. Available at premium bariatric centers in India (Medanta, Fortis, Apollo) and UAE (Cleveland Clinic Abu Dhabi, Burjeel Medical City).

SINGLE-INCISION LAPAROSCOPIC SLEEVE (SILS / SILSS): A specialized technique performed through a single multi-port umbilical incision. Offers superior cosmetic outcome (essentially scar-free). Technically demanding and typically reserved for BMI < 50 in centers with specific SILS expertise. Longer operative time and higher surgeon skill threshold limit widespread adoption.

MINI-SLEEVE (FUNDUS-PRESERVING SLEEVE) — INVESTIGATIONAL: A modified technique that preserves a small portion of the fundus to theoretically reduce GERD risk post-operatively. Not yet widely validated or endorsed by IFSO as a standard approach; currently under evaluation in prospective trials.

PHASE 1 — PRE-OPERATIVE PREPARATION (4–8 weeks before surgery):

• Remote consultation with GAF Healthcare's bariatric coordinator and assigned surgeon; submission of medical records for candidacy review
• Completion of all required pre-operative investigations (endoscopy, ECHO, sleep study, blood panel — many of which can be done in your home country and uploaded digitally)
• Initiation of pre-operative liver-shrinkage diet (high-protein, low-carbohydrate, approximately 1,000–1,200 kcal/day for 2–4 weeks prior to surgery)
• Cessation of anticoagulants, NSAIDs, oral contraceptives, and GLP-1 agonists per surgical team timeline
• Visa and travel logistics coordinated by GAF Healthcare (e-Medical Visa for India; UAE entry visa or visa-on-arrival processing)
• Pre-operative psychological and nutritional counseling sessions (virtual or in-person upon arrival)

PHASE 2 — ARRIVAL & IMMEDIATE PRE-OPERATIVE PERIOD (Day -1 to Day 0):